Compare GRWG & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRWG | CPIX |
|---|---|---|
| Founded | 2008 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 89.2M | 73.6M |
| IPO Year | 2015 | 2007 |
| Metric | GRWG | CPIX |
|---|---|---|
| Price | $1.11 | $3.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 338.5K | 172.3K |
| Earning Date | 01-01-0001 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $193,365,479.00 | $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 142.51 | 16.75 |
| 52 Week Low | $0.83 | $1.85 |
| 52 Week High | $2.40 | $6.70 |
| Indicator | GRWG | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 39.97 |
| Support Level | $1.05 | $3.40 |
| Resistance Level | $1.21 | $3.80 |
| Average True Range (ATR) | 0.06 | 0.30 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 42.31 | 2.63 |
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.